Placental transporter-mediated drug interactions and offspring congenital anomalies
Maria Ellfolk(Helsinki University Hospital), Heli Malm(University of Helsinki), Aleksi Tornio(University of Helsinki), Anna‐Maria Lahesmaa‐Korpinen(University of Helsinki), Mikko Niemi(University of Helsinki), Maarit K. Leinonen(University of Helsinki)
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
January 1, 2020
Cited by 0
Related Papers
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
|The Lancet Oncology|2017|510
Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
|JNCI Journal of the National Cancer Institute|2009|265
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability
|JAMA Neurology|2022|265
Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours
|European Journal of Cancer|2017|237
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy
|JAMA Internal Medicine|2023|172